Financing ·
Arcadia Biosciences, Inc. entered into a securities purchase agreement on June 11, 2026, for a private placement of…
RKDAArcadia Biosciences, Inc.
Arcadia Biosciences, Inc. entered into a securities purchase agreement on June 11, 2026, for a private placement of pre-funded warrants and investment options to an institutional investor for approximately $4 million in gross proceeds. The offering includes pre-funded warrants for up to 3,883,496 shares, Series A-1 and Series A-2 preferred investment options for an additional 3,883,496 shares, all at a purchase price of $1.0299 per unit. Arcadia Biosciences, Inc. is a biotechnology company focused on plant-based science and plant-based products.